Apex Labs Seeks FDA Approval for Study on Psilocybin Microdosing and Driver Safety

June 20, 2024

Cybin Appoints Atul Mahableshwarkar as Senior VP, Clinical Development

June 16, 2024

Optimi Health Receives Regulatory Approval to Export to Australia

June 3, 2024

Lykos Appoints Finance Veteran Scott Giacobello to Board of Directors

May 31, 2024

DEA: MIRA-55 Marijuana Analog Not a Controlled Substance

May 29, 2024

Psilocybin Clinical Trial for Mental-Health Workers Approved in Canada

May 24, 2024